Keeping Current CME podkast

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

0:00
38:19
Do tyłu o 15 sekund
Do przodu o 15 sekund

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Więcej odcinków z kanału "Keeping Current CME"